Fargesin T5S2178
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
1. Fargesin as a potential _1AR antagonist through cAMP/PKA pathway could protect against myocardial ischemia/reperfusion injury in rats. 2. Fargesin improves dyslipidemia and hyperglycemia by activating Akt and AMPK in WAT.
CAS nr:
31008-19-2
Purity:
98%
Molecular Weight:
370,4
SMILES:
COc1ccc(cc1OC)[C@@H]1OC[C@H]2[C@@H]1CO[C@@H]2c1ccc2OCOc2c1
Formula:
C21H22O6
Pathway:
Neuroscience,GPCR/G Protein
Target:
Adrenergic Receptor,Adrenergic Receptor
